OTTAWA, July 10, 2025 – Employers in Canada’s bio-economy will gain support with a new initiative addressing workplace sexual harassment. BioTalent Canada’s latest project, Building a safer bio-economy: Addressing sexual harassment in… Read More
ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) NORTH CHICAGO, Ill. and NEW YORK, July 10, 2025 /PRNewswire/ — AbbVie (NYSE: ABBV) and IGI Therapeutics SA,… Read More
VANCOUVER, British Columbia–(BUSINESS WIRE)–Life Sciences BC (LSBC) is pleased to announce the recipients of the 27th Annual Life Sciences BC Awards. These awards honour the exceptional achievements of individuals and… Read More
Vancouver (BC), Toronto (ON), and Montreal (QC) (July 9, 2025) — Canada has developed a world-class life sciences sector, but without stronger domestic investment, much of the economic value and intellectual… Read More
Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a open-label study to a Phase 2b placebo-controlled study. This is… Read More
